Fundraising FoxVantis Vascular
San Jose, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Vantis Vascular
Sign up to see every warm intro you have to Vantis Vascular
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vantis Vascular team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose
Founders & leadership
MM
Marc MonahanChief Financial OfficerMarc Monahan is a finance executive with over 30 years of experience in software, life sciences, and renewable energy. He has led multiple companies through IPOs and acquisitions, raised more than $300 million in debt and equity financing, and guided post-acquisition integrations across various organizations.
MM
Mike MirizziChief Technology OfficerMike Mirizzi is an R&D executive with experience developing medical device products across disposables, catheters, and capital equipment from conception through commercialization at startups and larger companies. He has led engineering teams and managed projects spanning preclinical testing, clinical studies, manufacturing transfer, and product launch for vascular intervention and other medical device applications.
FS
Frank SaltielChief Clinical OfficerFrank Saltiel holds an M.D. from Northwestern University and has experience in clinical research, medical education, and medical device development within healthcare. He serves as Executive Officer and Director at Vantis Vascular, which develops vascular intervention technology including integrated delivery systems and intravascular lithotripsy solutions.
TF
Tim FischellChief Medical Officer
Board
LP
Len PinchukBoard director
Investors · 1
Funding
SEC filings, press & company announcements$46.7M disclosed across 7 rounds · 2018–2026
- $5MSAFEMay 2024 · 2 sourcesSource ↗
▶$18.6MraisedJul 2026 · 123 investors · OtherRule 506(b)
▶$18.6MraisedJul 2026 · 123 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tim FischellExecutive Officer, Director
- Frank SaltielExecutive Officer, Director
- Len PinchukDirector
- Jason TurnerExecutive Officer, Director
- Marc MonahanExecutive Officer
- Mike MirizziExecutive Officer
- Gary McCordExecutive Officer
- Offering amount
- $21.5M
- Amount sold
- $18.6M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.3MraisedOct 2024 · 114 investors · OtherRule 506(b)
▶$14.3MraisedOct 2024 · 114 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Len PinchukDirector
- Gary McCordExecutive Officer
- Tim FischellExecutive Officer, Director
- Marc MonahanExecutive Officer
- Mike MirizziExecutive Officer
- Jason TurnerExecutive Officer, Director
- Frank SaltielExecutive Officer, Director
- Offering amount
- $22.2M
- Amount sold
- $14.3M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedFeb 2022 · 73 investors · OtherRule 506(b)
▶$7MraisedFeb 2022 · 73 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Frank SaltielExecutive Officer, Director
- Jason TurnerExecutive Officer, Director
- Len PinchukDirector
- Tim FischellExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $7M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$503.5KraisedSep 2021 · 17 investors · OtherRule 506(b)
▶$503.5KraisedSep 2021 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Frank SaltielExecutive Officer, Director
- Tim FischellExecutive Officer, Director
- Len PinchukDirector
- Offering amount
- $800K
- Amount sold
- $503.5K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$700KraisedDec 2020 · 20 investors · OtherRule 506(b)
▶$700KraisedDec 2020 · 20 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Len PinchukDirector
- Frank SaltielExecutive Officer, Director
- Tim FischellExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $700K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$485KraisedDec 2018 · 14 investors · OtherRule 506(b)
▶$485KraisedDec 2018 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tim FischellExecutive Officer, Director
- Frank SaltielExecutive Officer, Director
- Len PinchukDirector
- Offering amount
- $1.8M
- Amount sold
- $485K
- Minimum investment
- $25K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Innova VascularInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
AngiodynamicsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Vantis Vascular.
Frequently asked questions
- What does Vantis Vascular do?
- Vantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose
- Who are Vantis Vascular's investors?
- Vantis Vascular's investors include SCP Ventures, LLC.
- How much funding has Vantis Vascular raised?
- Vantis Vascular has disclosed $46.7M raised across 7 rounds.
- Where is Vantis Vascular headquartered?
- Vantis Vascular is headquartered in San Jose, US.